Evidence map›Paper›PMID 37935015›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2023

[ROC curves: general characteristics and their usefulness in clinical practice].

Ivonne Analí Roy-García, Carlos Paredes-Manjarrez, Jorge Moreno-Palacios, Rodolfo Rivas-Ruiz, Andrey Arturo Flores-Pulido

Abstract readEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Advances in laboratory medicine · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ivonne Analí Roy-GarcíaInstituto Mexicano del Seguro Social, Coordinación de Investigación en Salud, Centro de Adiestramiento e Investigación Clínica. Ciudad de México, México.ORCID 0000-0002-1859-3866
Carlos Paredes-ManjarrezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Departamento de Imagenología. Ciudad de México, México.ORCID 0000-0002-3319-7634
Jorge Moreno-PalaciosInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Departamento de Urología. Ciudad de México, México.ORCID 0000-0001-9994-4922
Rodolfo Rivas-RuizInstituto Mexicano del Seguro Social, Coordinación de Investigación en Salud, Centro de Adiestramiento e Investigación Clínica. Ciudad de México, México.ORCID 0000-0002-5967-7222
Andrey Arturo Flores-PulidoInstituto Politécnico Nacional, Escuela Superior de Medicina, Sección de Posgrado. Ciudad de México, México.ORCID 0000-0002-3358-1054

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of diagnostic tests to determine the presence or absence of a disease is essential in clinical practice. The results of a diagnostic test may correspond to numerical estimates that require quantitative reference parameters to be transferred to a dichotomous interpretation as normal or abnormal and thus implement actions for the care of a condition or disease. For example, in the diagnosis of anemia it is necessary to define a cut-off point for the hemoglobin variable and create two categories that distinguish the presence or absence of anemia. The method used for this process is the preparation of diagnostic performance curves, better known by their acronym in English as ROC (Receiver Operating Characteristic). The ROC curve is also useful as a prognostic marker, since it allows defining the cut-off point of a quantitative variable that is associated with greater mortality or risk of complications. They have been used in different prognostic markers in COVID-19, such as the neutrophil/lymphocyte ratio and D-dimer, in which cut-off points associated with mortality and/or risk of mechanical ventilation were identified. The ROC curve is used to evaluate the diagnostic performance of a test in isolation, but it can also be used to compare the performance of two or more diagnostic tests and define which one is more accurate. This article describes the basic concepts for the use and interpretation of the ROC curve, the interpretation of an area under the curve (AUC) and the comparison of two or more diagnostic tests.

Indexed as

AnemiaLymphocytesHumansROC CurveÁrea Bajo la CurvaArea Under CurveCurva ROCDiagnostic Techniques and ProceduresEstadísticaROC CurveStatisticsTécnicas y Procedimientos Diagnósticos

Identifiers

PMID37935015
PMCPMC10754459

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.